Literature DB >> 4332090

[Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].

A M Landolt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4332090     DOI： 10.1007/bf01405412

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


× No keyword cloud information.
  7 in total

1.  The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice.

Authors:  Y MATSUKADO; C S MACCARTY; J W KERNOHAN
Journal:  J Neurosurg       Date:  1961-09       Impact factor: 5.115

2.  [Anamnesis and clinical picture of glioblastoma multiforme].

Authors:  H KRAYENBUEHL
Journal:  Acta Neurochir Suppl (Wien)       Date:  1959

3.  Current trends in the chemotherapy of brain tumors with special reference to glioblastomas.

Authors:  C B Wilson; T Hoshino
Journal:  J Neurosurg       Date:  1969-12       Impact factor: 5.115

4.  Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).

Authors:  K Sano; T Hoshino; M Nagai
Journal:  J Neurosurg       Date:  1968-06       Impact factor: 5.115

5.  Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy).

Authors:  K Sano; F Sato; T Hoshino; M Nagai
Journal:  Neurol Med Chir (Tokyo)       Date:  1965       Impact factor: 1.742

6.  The treatment of glioblastoma multiforme of the brain.

Authors:  R Jelsma; P C Bucy
Journal:  J Neurosurg       Date:  1967-11       Impact factor: 5.115

7.  The Kentucky Conference on Brain Tumor Chemotherapy.

Authors:  E A Bering; C B Wilson; H A Norrell
Journal:  J Neurosurg       Date:  1967-07       Impact factor: 5.115
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.